Natalizumab is a recombinant, humanized IgG4 monoclonal antibody that binds α4β1 integrin and prevents its interaction with vascular cell adhesion molecule-1. Supplied as a liquid solution for research use, the product is intended for studies of immune cell adhesion, migration, and inflammatory disease models; follow the datasheet for storage and handling and dilute or reconstitute with sterile PBS or saline as indicated.
- Recombinant humanized IgG4 monoclonal antibody.
- Binds α4β1 integrin and blocks VCAM-1 interaction.
- Supplied as a liquid solution, ready for dilution or reconstitution.
- Suitable for studies of immune cell adhesion, migration, and inflammatory disease models.
- High purity (≥99.0%) and molecular weight approximately 146 kDa; consult the datasheet for storage and handling.